Barceloneta, Puerto Rico (APL) Contract Manufacturing Capabilities

AbbVie’s Barceloneta pharmaceutical manufacturing facility lies within 70 miles of the Puerto Rican capital, San Juan. The state-of-the-art plants provide modern drug finishing and biologics for countries around the world. 


AbbVie's Barceloneta location is actually two facilities on the island's northern coast. One produces traditional small molecule drug products, including controlled drug production. The second makes monoclonal antibody APIs. They are part of several AbbVie facilities providing biologics around the world.

Cutting-Edge Biopharmaceuticals

Our Barceloneta operation is one of the world's most advanced biopharmaceutical facilities. It is FDA-approved for commercial manufacturing, with 12,000 L bioreactors and more than 80 tanks and vessels. The drug product facility offers large-scale tablet and capsule processing, as well as potent and non-potent hot melt extrusion (HME).

AbbVie’s Barceloneta contract manufacturing expertise:

  • Biologic - Commercial
  • Tablet Coating
  • Massing Granulation (High Shear)
  • Capsules
  • Particle Coating
  • Bi-layer Tablets
  • Direct Compression (Dry Blend)
  • Hot Melt Extrusion
  • Liquids
  • Pre-filled Syringe

An AbbVie CMO representative is eager to talk to you.

AbbVie CMO is a seasoned partner for all your contract manufacturing needs. Let’s start a conversation today. The future is a click away.